Healthdyne takeover fight goes to court
This article was originally published in Clinica
Executive Summary
A US court could rule this week on a key element of Invacare's long-running hostile takeover bid for Healthdyne Technologies. At stake at the federal court hearing will be whether Healthdyne's anti-takeover defence mechanism should be overturned to allow shareholders to vote on new directors who support Invacare, says Invacare lawyer Mark Harnett. Invacare has asked for an expedited ruling prior to Healthdyne's annual meeting on July 30.